Amicus Therapeutics Inc [NASDAQ: FOLD] closed the trading session at $10.43. The stocks have a year to date performance of -26.50 percent and weekly performance of -1.04 percent. The stock has been moved at -4.49 percent over the last six months. The stock has performed
Amicus Therapeutics Inc [NASDAQ: FOLD] loss -1.02% or -0.11 points to close at $10.71 with a heavy trading volume of 3985123 shares. The daily chart for FOLD points out that the company has recorded -1.74% loss over the past six months. If we look at
Amicus Therapeutics Inc [NASDAQ: FOLD] traded at a low on Wednesday, posting a -0.09 loss after which it closed the day’ session at $10.55. The results of the trading session contributed to over 2441659 shares changing hands. Over the past one week, the price volatility
Amicus Therapeutics Inc [NASDAQ: FOLD] loss 0.00% or 0.0 points to close at $11.37 with a heavy trading volume of 3866683 shares. The company report on March 20, 2024 at 7:00 AM that Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report. “Since the
Amicus Therapeutics Inc [NASDAQ: FOLD] price surged by 2.25 percent to reach at $0.26. The company report on March 1, 2024 at 7:00 AM that Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024. Cowen 44th Annual Health Care Conference in Boston, MA,
Amicus Therapeutics Inc [NASDAQ: FOLD] gained 0.17% on the last trading session, reaching $11.81 price per share at the time. The company report on March 1, 2024 at 7:00 AM that Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024. Cowen 44th Annual
Amicus Therapeutics Inc [NASDAQ: FOLD] stock went on a downward path that fall over -5.62% on Wednesday, amounting to a one-week price decrease of less than -2.70%. The company report on March 1, 2024 at 7:00 AM that Amicus Therapeutics to Present at Upcoming Investor
Amicus Therapeutics Inc [NASDAQ: FOLD] gained 0.51% on the last trading session, reaching $13.85 price per share at the time. The company report on February 15, 2024 at 7:00 AM that Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024. Participants
Amicus Therapeutics Inc [NASDAQ: FOLD] price surged by 6.22 percent to reach at $0.82. The company report on February 15, 2024 at 7:00 AM that Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024. Participants and investors interested in accessing the
Amicus Therapeutics Inc [NASDAQ: FOLD] price surged by 1.93 percent to reach at $0.24. The company report on February 1, 2024 at 7:00 AM that Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024. The one-year FOLD stock forecast points to a
© 2024, Powered by Smart TechOne
